trial
as of 2026-07-01Improving Visual Attention in Schizophrenia
NCTId NCT03880227
at a glance
— · Completed
Enrollment 81 (actual)
Sponsored by The University of Texas at Dallas
Primary completion 2020-03-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
81 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2019-03-25
Primary completion
2020-03-04
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
The University of Texas at DallasLead Sponsor
Investigators
1
Hans S Klein, MSPrincipal Investigator
Sites
1 total
Richardson, United States
Facts & assertions
4 sourced
Enrollment
81
Phase
NA
Primary Completion Date
2020-03-04
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person